The heart medication beta-blockers reduce the risk of subsequent heart attacks in patients with either no or mild heart damage, according to two new large-scale studies. These findings may have significant implications for clinical practice worldwide.
Many cardiologists have been uncertain about the usefulness of beta-blockers for all patients who have experienced a heart attack. Patients and hospitals from across Norway have contributed to new research on the effectiveness of this medication. Illustration image: Colourbox.com
/University of Oslo Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
